comparemela.com

ஸ்கைஹாக் சிறிய News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development

Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development News provided by Share this article Share this article Elliot Ehrich MD brings 25+ years R&D and clinical development leadership experience to the company; Graeme Smith PhD DABT brings 15+ years of nonclinical drug development leadership experience to the company. WALTHAM, Mass., April 13, 2021 /PRNewswire/  Skyhawk Therapeutics today announced the appointments of Dr. Elliot Ehrich as its President, and Dr. Graeme Smith as its Senior Vice President of Nonclinical Development. Skyhawk builds novel small molecule RNA modifying drug candidates for deployment across a wide range of oncology, neurology and autoimmune diseases.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.